Terminated NA INTERVENTIONAL 2-arm NCT02158013

Treatment Of Chronic Anal Fissure (TOCA)

Treatment Of Chronic Anal Fissure (TOCA): a Randomized Clinical Trial on Levorag® Emulgel Versus Diltiazem Gel 2%

Sponsor: Bispebjerg Hospital

Updated 9 times since 2017 Last updated: Jan 13, 2020 Started: Sep 1, 2014 Primary completion: Feb 5, 2018 Completion: Feb 5, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Slow inclusion rate

Other terminated trials from Bispebjerg Hospital

See all terminations from Bispebjerg Hospital

Listed as NCT02158013, this NA trial focuses on Chronic Anal Fissure and remains terminated or withdrawn. Sponsored by Bispebjerg Hospital, it has been updated 9 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2021 — Jul 2024 [monthly]

Terminated NA
Feb 2020 — Jan 2021 [monthly]

Terminated NA

Status: Unknown Status → Terminated
Dec 2019 — Feb 2020 [monthly]

Unknown Status NA

Status: Active Not Recruiting → Unknown Status

▶ Show 4 earlier versions

May 2019 — Dec 2019 [monthly]

Active Not Recruiting NA
Jun 2018 — May 2019 [monthly]

Active Not Recruiting NA
Dec 2017 — Jun 2018 [monthly]

Active Not Recruiting NA

Status: Recruiting → Active Not Recruiting
Jan 2017 — Dec 2017 [monthly]

Recruiting NA

First recorded

Sep 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bispebjerg Hospital
Sacomed

Data source: Bispebjerg Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Aarhus, Denmark
• Copenhagen, Denmark